About
Nancy Sullivan joined Illinois Ventures as CEO and Managing Director in 2013 and oversees all aspects of investing, operations and strategy as well as actively participates in guiding portfolio company growth. She is passionate about Illinois Ventures’ mission to make the world a better, healthier, and more accessible place through return-focused seed and early investment in healthcare and technology. Nancy led the fundraise of Illinois Ventures’ third venture capital fund, Illinois Emerging Technologies Fund III, which has invested in leading life science and technology companies across the Midwest and throughout the country. Under her leadership, Illinois Ventures has invested in over 30 life science and technology ventures alongside other top-tier investors and experienced business leaders. She led investments in life science companies including Revolution Medicines (RVMD), which entered the public market in 2020. In her role as the CEO and Managing Director, she led the team’s
Position in the VCSift Database
- • 25 investors hold the CEO & Managing Director role in VCSift. Nancy Sullivan is one of them.
- • 2,799 investors are based in United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- US
Contact Information
Find more investors like Nancy
Search Investors